330 related articles for article (PubMed ID: 8827098)
1. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
[TBL] [Abstract][Full Text] [Related]
2. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
[TBL] [Abstract][Full Text] [Related]
3. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.
Shreve MR; Johnson SJ; Milla CE; Wielinski CL; Regelmann WE
Am J Respir Crit Care Med; 1997 Mar; 155(3):984-9. PubMed ID: 9117036
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
[TBL] [Abstract][Full Text] [Related]
7. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran.
Dallal MM; Telefian CF; Hajia M; Kalantar E; Dehkharghani AR; Forushani AR; Khanbabaei Q; Mobarhan M; Farzami MR
J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029
[TBL] [Abstract][Full Text] [Related]
8. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
[TBL] [Abstract][Full Text] [Related]
9. Burkholderia cepacia complex infection in patients with cystic fibrosis.
Mahenthiralingam E; Baldwin A; Vandamme P
J Med Microbiol; 2002 Jul; 51(7):533-538. PubMed ID: 12132768
[TBL] [Abstract][Full Text] [Related]
10. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.
Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ
J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992
[TBL] [Abstract][Full Text] [Related]
11. Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.
Amalfitano G; Tonolli E; Favari F; Perazzoli C; Cazzola G; Mastella G; Piacentini I
Eur J Epidemiol; 1996 Apr; 12(2):149-53. PubMed ID: 8817193
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
[TBL] [Abstract][Full Text] [Related]
13. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
[TBL] [Abstract][Full Text] [Related]
14. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
[TBL] [Abstract][Full Text] [Related]
15. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
[TBL] [Abstract][Full Text] [Related]
16. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.
Crowley D; Daly M; Lucey B; Shine P; Collins JJ; Cryan B; Moore JE; Murphy P; Buckley G; Fanning S
J Appl Microbiol; 2002; 92(5):992-1004. PubMed ID: 11972706
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.
Vu-Thien H; Moissenet D; Valcin M; Dulot C; Tournier G; Garbarg-Chenon A
Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
